News

Ipsen, a global biotechnology specialty care group and the TMX-67 licensee in Europe, and its sublicensee the Menarini Group, have began marketing the product in Europe under the

WuXi PharmaTech posted a net income of $12.13m, compared to net loss of $93.85m for the comparable period in 2008. Operating income was $13.58m, compared to operating loss

Varian is a supplier of scientific instruments and vacuum technologies for life science, environmental, energy and applied research and other applications. The company provides complete solutions, including instruments,

Brian Scanlan, chief business officer of Cambridge Major Laboratories, said: “Chemistry Playbook accelerates drug development from carbon to commercialization by delivering where other competitive, expedited programs fall short:

CINtec Plus will be launched with claims direct in Germany, Italy, Spain, France and the UK, and will also be available in other parts of the world via

Wacker Chemie said that the expansion will enable it to accommodate its customers’ growing demand for biotechnologically manufactured pharmaceuticals. Biologics are used to treat, among other things, cancer,

Reportedly, the British-Swedish pharma major had filed two lawsuits against Sun Pharma and its US subsidiary on February 26 in a federal court in Trenton, New Jersey, and

As per the agreement, Nabi will be entitled to receive an upfront payment of $40m and GSK will be granted an option to exclusively in-license NicVAX on a

The grant has been designed to shrink technology found in large hospital hematology analyzers, typically the size of small refrigerators, to a tiny, palm-sized device. The emergency blood